0930 Sonoma
BioCentury & Getty Images


Sonoma tops off series A as it builds broader Treg therapy pipeline 

Janssen vet Dragone hired as CMO 

Oct 1, 2020 | 1:30 AM GMT

With an extra $30 million in series A funding, Sonoma is expanding the range of indications for its immunosuppressive Treg cell therapy pipeline, and exploring combination

Read the full 546 word article

How to gain access

Continue reading with a
two-week free trial.